BioSpace News Archive

Moberg Pharma AB has completed the recruitment of 452 patients with onychomycosis for the ongoing MOB-015 phase 3 study in Europe.

Inviting Artists to visit The Ambassador Photo Studio at the Villain Arts Chicago Tattoo Arts Convention March 22-24

Award-winning provider of non-medical home care ranked No. 100 on Entrepreneur list

Participating in the Blue Cross Blue Shield Alliance for Health Research, the study comes from Yale’s School of Public Health and School of Medicine

PAM Rehabilitation Hospital of Tulsa, which is part of the Post Acute Medical network of hospitals, will expand patient access to inpatient medical rehabilitation care with the addition of 13 beds.

BTB Security, a cybersecurity consulting and advisory firm, today announced its sponsorship of The CyberPatriot National Youth Cyber Education Program which encourages students to explore careers in cybersecurity.

OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on ovarian cancer and soft tissue sarcoma Tuesday, March 26, from 5 to 9 p.m. at the Millennium Hilton New York in New York City.

Bold Insight, a user experience (UX) and human factors (HF) research agency, is proud to be awarded ISO 9001:2015 certification from NSF-ISR.

ALZPROTECT, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer’s disease, today announced that PAREXEL Biotech, a new division of PAREXEL International Corporation, has been selected to perform the clinical phase 2a development of AZP2006 for the treatment of PSP, a rare degenerative disease of the brain.

CysBio is making cost-effective and novel biochemicals via sustainable fermentation processes. Through advanced synthetic biology and metabolic engineering approaches microorganisms are engineered to convert simple sugars into desired biochemical products.